Benlysta 200 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25FVJYN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $12,306
Award facts
- Contract value 100% obligated
- $12,305.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Benlysta 200 mg/ml syringes valued at $12,305.60 with an ultimate completion date of October 7, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. Benlysta (belimumab), a biologic immunosuppressant used to treat systemic lupus erythematosus, represents one of the specialized pharmaceutical products the company supplies through its federal contracts to support military healthcare programs worldwide. AmerisourceBergen's demonstrated capability in fulfilling federal medical supply requirements through open competition, combined with its established prime vendor relationship with DLA, positions it to supply critical pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DX25FVJYN?
SPE2DX25FVJYN was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 16, 2025.
How much is contract SPE2DX25FVJYN worth?
The government has obligated $12,306 on SPE2DX25FVJYN.
Is contract SPE2DX25FVJYN an order under another contract?
Yes. SPE2DX25FVJYN is a delivery order under SPE2DX15D1022, an indefinite delivery contract.
Was contract SPE2DX25FVJYN competed?
The extent of competition for SPE2DX25FVJYN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award